Also listed on Valneva SE, an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Oct 20, 2025 (Biopharma Credit PLC).
Term ends Mar 14, 2033 · High confidence
20-year base term ends Jan 9, 2035
Held by Valneva Austria GmbH
Filed Aug 11, 2020 as application 16/990,023 · Granted Feb 7, 2023
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
2015
2035
Clock starts
Jan 9, 2015
Jan 9, 2015
Term ends
Mar 14, 2033
Mar 14, 2033
Granted
Feb 7, 2023
Feb 7, 2023
base term
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,766,931, US 9,975,927.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 9, 2015, when application PCT/EP2015/050365, the earliest non-provisional in its chain, was filed (this one was filed Aug 11, 2020) | Jan 9, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,766,931, US 9,975,927) | capped to Mar 14, 2033 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 14, 2033 | High confidence |
This family
| US 9,975,927 | In force Jan 2035 | Jan 2035 |
| US 10,766,931 | In force Mar 2033 | Mar 2033 |
| US 11,572,392 | this patent Mar 2033 | Mar 2033 |
| Application 18/150,971 | Abandoned not computed | not computed |
| Application 19/386,871 | Pending not computed | not computed |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 16, 2020 Reel 54375, frame 631 | Lundberg, Urban; Schüler, Wolfgang | Valneva Austria GmbH | Assignment of Assignor's Interest |
| Jan 19, 2024 Reel 66182, frame 174 | Valneva SE; Valneva Austria GmbH; Valneva USA, Inc.; Valneva Sweden AB | Wilmington Trust, National Association | Security Interest |
| Oct 20, 2025 Reel 73164, frame 32 | Valneva Austria GmbH; Valneva SE; Valneva Sweden AB | Biopharma Credit PLC, as Collateral Agent | Patent Security Agreement |
| Nov 10, 2025 Reel 73516, frame 522 | Wilmington Trust, National Association, as Administrative Agent | Valneva Austria GmbH; Valneva SE; Valneva USA, Inc. | Release of Security Interest |
| Nov 10, 2025 reel/frame not recorded | Wilmington Trust, National Association, as Administrative Agent | Valneva Austria GmbH | Release of Security Interest |
| Nov 10, 2025 reel/frame not recorded | Wilmington Trust, National Association, as Administrative Agent | Valneva SE | Release of Security Interest |
| Nov 10, 2025 reel/frame not recorded | Wilmington Trust, National Association, as Administrative Agent | Valneva USA, Inc. | Release of Security Interest |
| Mar 31, 2026 Reel 75335, frame 609 | Valneva Austria GmbH; Valneva SE; Valneva Sweden AB | Biopharma Credit PLC, as Collateral Agent | Amended and Restated Patent Security Agreement |
| Jun 4, 2026 Reel 75803, frame 558 | Valneva Austria GmbH; Valneva SE; Valneva Sweden AB | Biopharma Credit PLC, as Collateral Agent | Amended and Restated Patent Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2033
Term ends Mar 14, 2033. Maintenance fees still fall due before then
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,766,931, US 9,975,927.
Citations
7
later US patents cite this one
That is top 10% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.